Dr. Judith Dunn is a member of Roche's pharma Research and Early Development Leadership Team, focused on discovery and development of new medications that significantly improve the lives of patients . As Vice President of Clinical Development, Judy leads several functions which contribute to the design and execution of clinical programs in the areas of Immunology & Inflammation, Infectious Diseases, Neuroscience, Oncology, Ophthalmology, and Rare Diseases. Judy also heads the Roche Innovation Center, NYC.
Judy has more than 25 years of international experience in the pharmaceutical industry. She began her career as a discovery scientist in biotech, held positions in both the research and commercial divisions of Pfizer, and led Psychiatry Clinical Development efforts at Sepracor, a specialty pharma company. Judy attended Wesleyan University and the University of Rochester, obtaining undergraduate and graduate degrees in Neurobiology. She was the recipient of a Research Fellowship in Neuropharmacology from the Center for Brain Research at Strong Memorial Hospital, as well as a Postdoctoral Fellowship in Clinical Research from Pfizer.
Judy serves as Chair of NewYorkBIO where she works to promote collaboration and growth in the New York life sciences community.